Candida Glabrata: An emerging threat for the Immunocompromised

Muhammad Akbar Agha, Shaheen Akbar Agha, Shaheen Sharafat, Muhammad Naveed uz Zafar, Muhammad Rafique Khanani, Muhammad Amir Mirza

Abstract



Background: Fungal infections cause a significant amount of morbidity and mortality among immuno compromised population. Various fungal agents are responsible but candida are one the most frequently isolated ones. Recently, a redistribution of candida species has been observed that has highlighted a non Candida albicans species i.e. Candida glabrata. High frequency of Candida glabrata exhibits high resistance rates and it has emerged as a difficult to treat pathogen. The objective of this study was to identify the various strains of fungi and their sensitivity in immuno compromised patients.

Material & Methods: This was a cross-sectional study in which immunocompromised patients were screened for fungal infections on the basis of conventional and API 20-C methods. In this study 165 cases were inducted that included cases on dialysis, chemotherapy for malignancies, those with transplant and receiving immunosuppressive therapy and were positive for fungal infections.

Results: Candida glabrata was isolated from 39(23.6%) cases and of these isolates, 13% were resistant to fluconazole.

Conclusion: Apart from Candida albicans, Candida glabrata is another difficult to treat fungal agent in immunocompromised patients.


Full Text:

PDF

Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Muhammad Akbar Agha, Shaheen Akbar Agha, Shaheen Sharafat, Muhammad Naveed uz Zafar, Muhammad Rafique Khanani, Muhammad Amir Mirza

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.